Metagenomi is kicking off the new year the way we all wish we were - with an extra $100 million. The biotech scored the cash in a Series B extension financing round announced Thursday, bringing its total Series B to $275 million.
The financing round was led by Leaps by Bayer, Moderna and several others, signaling that Metagenomi’s efforts in 2022 did not go unnoticed by its big pharma peers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,